Teresa Chiaverotti

Company: SillaJen Inc.

Job title: Director, New Drug Development

Seminars:

Implementing Diverse Tumor Models to Study & Develop Oncolytic Virus Therapies 2:15 pm

Highlighting the importance of understanding the dynamic interplay between oncolytic viruses and the immune system within tumor models to optimize therapeutic outcomes Addressing challenges such as virus delivery, tumor heterogeneity, and more, and strategies to overcome these hurdles Presenting strategies to overcome the discrepancies between data from different tumor modelsRead more

day: Conference Day One - Track 1 - Post Lunch